Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
IRLAB Therapeutics
IRLAB Publishes Interim Report for The Period January – June 2026
August 26, 2026
IRLAB: Invitation to The Interim Report for Q2 2026 Presentation and Webcast
August 20, 2026
IRLAB’s Drug Candidate IRL757 Receives the Generic Name Linepemat from The WHO
August 19, 2026
New Number of Shares and Votes in IRLAB Therapeutics AB
July 31, 2026
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
IRLAB Participates at Aktiedagarna in Stockholm on June 9
June 3, 2026
←
Previous Page
1
2